These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36074252)

  • 21. Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.
    Singh H; Gupta V; Ray S; Kumar H; Talapatra P; Kaur M; Kumar S; Arya S; Mathur R; Ghangas N
    Clin Rheumatol; 2012 Dec; 31(12):1663-9. PubMed ID: 22983768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID).
    Dougados M; Brault Y; Logeart I; van der Heijde D; Gossec L; Kvien T
    Arthritis Res Ther; 2012 May; 14(3):R129. PubMed ID: 22647431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cumulative patient-based disease activity monitoring in rheumatoid arthritis - predicts sustained remission, flare and treatment escalation.
    Leung MH; Choy EHS; Lau CS
    Semin Arthritis Rheum; 2020 Aug; 50(4):749-758. PubMed ID: 32531504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.
    Sokka T; Toloza S; Cutolo M; Kautiainen H; Makinen H; Gogus F; Skakic V; Badsha H; Peets T; Baranauskaite A; Géher P; Ujfalussy I; Skopouli FN; Mavrommati M; Alten R; Pohl C; Sibilia J; Stancati A; Salaffi F; Romanowski W; Zarowny-Wierzbinska D; Henrohn D; Bresnihan B; Minnock P; Knudsen LS; Jacobs JW; Calvo-Alen J; Lazovskis J; Pinheiro Gda R; Karateev D; Andersone D; Rexhepi S; Yazici Y; Pincus T;
    Arthritis Res Ther; 2009; 11(1):R7. PubMed ID: 19144159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR.
    Melikoglu MA; Ataman S; Bodur H; Cay HF; Capkin E; Akgul O; Cevik R; Gogus F; Kamanli A; Yurdakul FG; Gurer G; Yagci I; Rezvani A; Duruoz MT; Sunar I
    Rheumatol Int; 2021 Nov; 41(11):1971-1978. PubMed ID: 34559275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poor to modest agreement between rheumatoid arthritis response measures in clinical practice.
    Michaud K; Mikuls TR; Call SE; Reimold AM; Hooker R; Kerr GS; Richards JS; Caplan L; Cannon GW
    Clin Exp Rheumatol; 2009; 27(4):633-40. PubMed ID: 19772796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis.
    Sauer BC; Chen W; Xu Y; Shen J; Accortt NA; Collier DH; Cannon GW
    Arthritis Res Ther; 2020 Oct; 22(1):253. PubMed ID: 33092642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study.
    Raheel S; Matteson EL; Crowson CS; Myasoedova E
    Rheumatology (Oxford); 2017 Dec; 56(12):2154-2161. PubMed ID: 28968703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients.
    Morris NT; Brook J; Ben-Artzi A; Martin W; Kermani TA; Avedikian-Tatosyan L; Karpouzas G; Nagam H; Navarro G; Choi S; Taylor MB; Elashoff D; Kaeley GS; Ranganath VK
    Clin Rheumatol; 2021 Dec; 40(12):5055-5065. PubMed ID: 34269927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.
    Kumar BS; Suneetha P; Mohan A; Kumar DP; Sarma KVS
    Indian J Med Res; 2017 Nov; 146(Supplement):S57-S62. PubMed ID: 29578196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
    Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
    Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimization of flare management in patients with rheumatoid arthritis: results of a randomized controlled trial.
    Myasoedova E; Crowson CS; Giblon RE; McCarthy-Fruin K; Schaffer DE; Wright K; Matteson EL; Davis JM
    Clin Rheumatol; 2019 Nov; 38(11):3025-3032. PubMed ID: 31264032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can flare be predicted in DMARD treated RA patients in remission, and is it important? A cohort study.
    Saleem B; Brown AK; Quinn M; Karim Z; Hensor EM; Conaghan P; Peterfy C; Wakefield RJ; Emery P
    Ann Rheum Dis; 2012 Aug; 71(8):1316-21. PubMed ID: 22294638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.
    Singh JA; Hossain A; Tanjong Ghogomu E; Mudano AS; Maxwell LJ; Buchbinder R; Lopez-Olivo MA; Suarez-Almazor ME; Tugwell P; Wells GA
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012591. PubMed ID: 28282491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren's syndrome enrolled in a large observational US registry.
    Harrold LR; Shan Y; Rebello S; Kramer N; Connolly SE; Alemao E; Kelly S; Kremer JM; Rosenstein ED
    Rheumatol Int; 2020 Aug; 40(8):1239-1248. PubMed ID: 32449040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway.
    Haugeberg G; Hansen IJ; Soldal DM; Sokka T
    Arthritis Res Ther; 2015 Aug; 17(1):219. PubMed ID: 26290061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients and clinicians define symptom levels and meaningful change for PROMIS pain interference and fatigue in RA using bookmarking.
    Bingham CO; Butanis AL; Orbai AM; Jones M; Ruffing V; Lyddiatt A; Schrandt MS; Bykerk VP; Cook KF; Bartlett SJ
    Rheumatology (Oxford); 2021 Sep; 60(9):4306-4314. PubMed ID: 33471127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The problem of rheumatoid arthritis disease activity and remission in clinical practice.
    Shaver TS; Anderson JD; Weidensaul DN; Shahouri SH; Busch RE; Mikuls TR; Michaud K; Wolfe F
    J Rheumatol; 2008 Jun; 35(6):1015-22. PubMed ID: 18412311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial.
    Smolen JS; Szumski A; Koenig AS; Jones TV; Marshall L
    Arthritis Res Ther; 2018 Jan; 20(1):8. PubMed ID: 29338762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.